Skip to main content
. 2026 May 20;18(5):625. doi: 10.3390/pharmaceutics18050625
BPC-157 Body Protection Compound 157
ADME Absorption, Distribution, Metabolism, and Excretion
BCS Biopharmaceutical Classification System
PK Pharmacokinetics
PD Pharmacodynamics
PK/PD Pharmacokinetic–Pharmacodynamic
VEGF Vascular Endothelial Growth Factor
VEGFR2 Vascular Endothelial Growth Factor Receptor 2
Egr-1 Early Growth Response 1
NO Nitric Oxide
eNOS Endothelial Nitric Oxide Synthase
HO-1 Heme Oxygenase-1
TNF-α Tumor Necrosis Factor Alpha
IL Interleukin
NF-κB Nuclear Factor Kappa B
LC-MS/MS Liquid Chromatography–Tandem Mass Spectrometry
Cmax Maximum Plasma Concentration
AUC Area Under the Curve
IM Intramuscular
IV Intravenous
SC Subcutaneous
CNS Central Nervous System
PLGA Poly(lactic-co-glycolic acid)
SNAC Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate
ICH International Council for Harmonisation
FDA Food and Drug Administration
EMA European Medicines Agency
WADA World Anti-Doping Agency
cGMP Current Good Manufacturing Practice
GLP Good Laboratory Practice